Atlas Trials

A Trial of Bardoxolone Methyl in Patients With CKD at Risk of Rapid Progression (MERLIN)

Clinical trial NCT04702997 · COMPLETED

Trial details

NCT number
NCT04702997
Sponsor
Biogen
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Chronic Kidney Diseases
Start date
2021-02-09
Primary completion
2021-10-20
Enrollment
81

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.